why choose us

First received: September 22, 2022

Clinical Trial: PROFAST Intervention in Precursor Multiple Myeloma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer Prevention

Study Type: INTERVENTIONAL


Official Title: PROlonged Nightly FASTing for Obesity Reduction and Prevention of Disease Prevention in Precursor Multiple Myeloma (PROFAST)

Brief Summary: This is a 4-month randomized trial of a prolonged nightly fasting intervention (PROFAST) in 40 overweight and obese individuals with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and smoldering waldenstrom macroglobulinemia (SWM).The purpose of this study is to understand if fasting for a prolonged period of time during the nighttime hours is a strategy to prevent overweight and obese individuals from developing blood cancer.Participants will be randomized into the…

Read more